Company Continues to Add to their Bitcoin Position Vancouver, BC – July 2, 2025 - TheNewswire – Planet Ventures Inc. (CSE: PXI; OTC: PNXPF) ("Planet Ventures" or the "Company"), an investment issuer focused on technology, mining and digital assets, is pleased to announce that it has completed an additional purchase of 3.37939441 Bitcoin for an aggregate purchase price of $500,000 CAD , using a portion of its existing cash reserves.
– Conditional approval based on positive results from the HERIZON-BTC-01 Phase 2b trial – DUBLIN , July 1, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the European Commission (EC) has granted conditional marketing authorization1 for Ziihera ® (zanidatamab), a dual human epidermal growth factor receptor 2 (HER2)-targeted bispecific antibody, as monotherapy for the treatment of adults with unresectable locally advanced or metastatic HER2-positive (IHC 3+)† biliary tract cancer (BTC) previously treated with at least one prior line of systemic therapy.2 BTCs, which include gallbladder cancer (GBC) and cholangiocarcinoma (CCA), are a rare and aggressive group of cancers,3 with most cases diagnosed at an advanced stage4 when curative surgery is no longer an option.5 , 6 , 7 Globally, approximately 26% of patients with BTC are HER2-positive,8 a biomarker associated with poorer outcomes compared to HER2-negative disease.9 Ziihera is the first HER2-targeted therapy given conditional authorization for HER2-positive BTC in the European Union (EU). Continued approval for this indication is contingent upon verification and description of clinical benefit in the ongoing Phase 3 HERIZON-BTC-302 trial, which is evaluating zanidatamab in combination with standard-of-care therapy versus standard-of-care therapy alone in the first-line setting for patients with HER2-positive BTC.10 "People with HER2-positive biliary tract cancer who progress after first-line therapy face a challenging prognosis, with limited treatment options, poor tolerability, and median overall survival of only six to nine months," said Arndt Vogel, MD, managing senior consultant and professor in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School, Germany.
Company Deploys Excess Cash into Strategic Bitcoin Position Vancouver, BC – June 27, 2025 – TheNewswire - Planet Ventures Inc. (CSE: PXI; OTC: PNXPF) ("Planet Ventures" or the "Company"), an investment issuer focused on technology, mining and digital assets, is pleased to announce that it has completed its first purchase of 3.40669032 Bitcoin for an aggregate purchase price of $500,000 CAD , using a portion of its existing cash reserves.
![]() BTC 27 Jun 2024 Paid | Quarterly | $0.19 Per Share |
![]() BTC 26 Mar 2024 Paid | Quarterly | $0.56 Per Share |
![]() BTC 27 Dec 2023 Paid | Quarterly | $0.65 Per Share |
![]() BTC 27 Sep 2023 Paid | Quarterly | $0.93 Per Share |
![]() BTC 28 Jun 2023 Paid | Quarterly | $0.17 Per Share |
![]() BTC 27 Jun 2024 Paid | Quarterly | $0.19 Per Share |
![]() BTC 26 Mar 2024 Paid | Quarterly | $0.56 Per Share |
![]() BTC 27 Dec 2023 Paid | Quarterly | $0.65 Per Share |
![]() BTC 27 Sep 2023 Paid | Quarterly | $0.93 Per Share |
![]() BTC 28 Jun 2023 Paid | Quarterly | $0.17 Per Share |
XMIL Exchange | US Country |
The fund discussed is an actively managed exchange-traded fund (ETF) that focuses on achieving its investment objective through a strategic portfolio of debt securities and debt-like instruments. By committing at least 80% of its net assets, along with any borrowings meant for investment purposes, this fund specifically targets debt securities that are economically akin to traditional debt instruments. The emphasis is on investing in instruments that are denominated in U.S. dollars and fall within the investment-grade category, highlighting the fund's preference for relatively safer, high-quality debt securities. Furthermore, the fund aims to manage its portfolio in a way that maintains a dollar-weighted average maturity ranging from zero to ten years, optimizing its balance between yield and maturity risk.
This service comprises the primary focus of the fund, where it invests in a variety of debt securities. These securities are chiefly denominated in U.S. dollars and are carefully selected to meet the fund's investment-grade requirement. By investing in these securities, the fund seeks to provide investors a stable and possibly lucrative return, derived from interest income and the potential for capital appreciation, all within the confines of maintaining a relatively low-risk investment posture.
As an actively managed ETF, the fund employs a strategic approach to managing its portfolio, with investment decisions guided by an in-depth analysis of market conditions, interest rate movements, and credit risk assessments. This active management allows the fund to adapt its investment strategies in real-time, aiming to optimize returns for investors by carefully selecting securities that offer the best risk-reward profiles within the scope of its investment mandate.
In line with its strategy to balance yield and risk, the fund maintains a keen focus on managing the maturity profiles of its portfolio's securities. By aiming to keep a dollar-weighted average portfolio maturity of zero to ten years, the fund strategically positions itself to mitigate interest rate risk while attempting to secure attractive yields for its investors. This approach underscores the fund's commitment to providing a thoughtful investment solution that caters to the varying risk tolerances and investment horizons of its clientele.